SARS-CoV-2 Human Challenge Characterisation Study

NCT04865237 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Covid19
SARS-CoV Infection
Corona Virus Infection
Coronavirus
COVID-19

Interventions

BIOLOGICAL: SARS-CoV-2 Virus 1x10^1 TCID50
DRUG: Remdesivir
BIOLOGICAL: SARS-CoV-2 Virus 1x10^2 TCID50
BIOLOGICAL: SARS-CoV-2 Virus 1x10^3 TCID50

Sponsor

Imperial College London

Collaborators

[object Object]
[object Object]